Lv4
640 积分 2021-06-14 加入
Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges
10天前
已完结
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study
11天前
已完结
Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee
11天前
已完结
Acute myeloid leukemia management and research in 2025
11天前
已完结
What Influences the Decision to Proceed to Transplant for Patients With AML in First Remission?
11天前
已完结
Does everyone with newly-diagnosed, untreated acute myeloid leukaemia need remission-induction chemotherapy before advancing to a transplant?
11天前
已完结
Towards precision medicine for AML
11天前
已完结
The global epidemiology of acute myeloid leukaemia
11天前
已完结
2025 Update on MRD in Acute Myeloid Leukemia: A Consensus Document from the ELN-DAVID MRD Working Party
14天前
已完结
A comprehensive review of immune checkpoint inhibitors for cancer treatment
1个月前
已完结
皖公网安备34019202002308
